Tussionex Pennkinetic

Catarrh, Migraine, Coughing + 55 more

Treatment

6 FDA approvals

20 Active Studies for Tussionex Pennkinetic

What is Tussionex Pennkinetic

Chlorpheniramine

The Generic name of this drug

Treatment Summary

An antihistamine used to treat allergies, hay fever, and asthma. It is commonly used because it typically causes less drowsiness and sedation than other antihistamines. It is also used to treat rhinitis and urticaria. It is sometimes used in veterinary applications.

Rynatuss

is the brand name

image of different drug pills on a surface

Tussionex Pennkinetic Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Rynatuss

Chlorpheniramine

1960

47

Approved as Treatment by the FDA

Chlorpheniramine, also known as Rynatuss, is approved by the FDA for 6 uses including Acute Bronchitis and Cold .

Acute Bronchitis

Used to treat Cough in combination with Hydrocodone

Cold

Used to treat Cold in combination with Hydrocodone

Allergic Rhinitis (AR)

Allergy to Tree Pollen

upper respiratory symptoms

Used to treat upper respiratory symptoms in combination with Hydrocodone

Hypersensitivity

Used to treat Allergic Reaction in combination with Hydrocodone

Effectiveness

How Tussionex Pennkinetic Affects Patients

Allergic reactions happen when an allergen triggers the IgE antibodies found on mast cells and basophils. This leads to the release of histamine, which can cause itching, flushing, headaches, low blood pressure, and difficulty breathing. Chlorpheniramine is a drug that works by blocking histamine from attaching to receptors in the body. This helps to reduce symptoms such as sneezing, itchy and watery eyes, and a runny nose due to allergies.

How Tussionex Pennkinetic works in the body

Chlorpheniramine stops histamine, a molecule in the body, from affecting cells. This helps to reduce symptoms caused by histamine, such as sneezing and itching.

When to interrupt dosage

The proposed dosage of Tussionex Pennkinetic is contingent upon the determined condition, including upper respiratory indications, Coughing and Inflammation. The measure of dosage fluctuates as per the technique of delivery (e.g. Kit; Syrup - Oral or Liquid - Oral) noted in the table beneath.

Condition

Dosage

Administration

Sinusitis

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Syrup - Oral, Syrup, Suspension - Oral, Suspension, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet - Oral, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Tablet, coated, Tablet, extended release, Tablet, extended release - Oral, Granule, Capsule - Oral, Granule - Oral, Suspension, extended release - Oral, Kit, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Suspension, extended release, Tablet, sugar coated - Oral, Tablet, multilayer, Lozenge - Oral, Tablet, chewable, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, chewable - Oral, Tablet, multilayer - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Solution / drops, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets

Seasonal Allergic Conjunctivitis

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Syrup - Oral, Syrup, Suspension - Oral, Suspension, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet - Oral, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Tablet, coated, Tablet, extended release, Tablet, extended release - Oral, Granule, Capsule - Oral, Granule - Oral, Suspension, extended release - Oral, Kit, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Suspension, extended release, Tablet, sugar coated - Oral, Tablet, multilayer, Lozenge - Oral, Tablet, chewable, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, chewable - Oral, Tablet, multilayer - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Solution / drops, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets

Lacrimal Apparatus Diseases

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Syrup - Oral, Syrup, Suspension - Oral, Suspension, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet - Oral, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Tablet, coated, Tablet, extended release, Tablet, extended release - Oral, Granule, Capsule - Oral, Granule - Oral, Suspension, extended release - Oral, Kit, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Suspension, extended release, Tablet, sugar coated - Oral, Tablet, multilayer, Lozenge - Oral, Tablet, chewable, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, chewable - Oral, Tablet, multilayer - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Solution / drops, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets

Coughing

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Syrup - Oral, Syrup, Suspension - Oral, Suspension, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet - Oral, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Tablet, coated, Tablet, extended release, Tablet, extended release - Oral, Granule, Capsule - Oral, Granule - Oral, Suspension, extended release - Oral, Kit, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Suspension, extended release, Tablet, sugar coated - Oral, Tablet, multilayer, Lozenge - Oral, Tablet, chewable, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, chewable - Oral, Tablet, multilayer - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Solution / drops, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets

Migraine

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Syrup - Oral, Syrup, Suspension - Oral, Suspension, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet - Oral, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Tablet, coated, Tablet, extended release, Tablet, extended release - Oral, Granule, Capsule - Oral, Granule - Oral, Suspension, extended release - Oral, Kit, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Suspension, extended release, Tablet, sugar coated - Oral, Tablet, multilayer, Lozenge - Oral, Tablet, chewable, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, chewable - Oral, Tablet, multilayer - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Solution / drops, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets

Pink Eye

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Syrup - Oral, Syrup, Suspension - Oral, Suspension, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet - Oral, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Tablet, coated, Tablet, extended release, Tablet, extended release - Oral, Granule, Capsule - Oral, Granule - Oral, Suspension, extended release - Oral, Kit, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Suspension, extended release, Tablet, sugar coated - Oral, Tablet, multilayer, Lozenge - Oral, Tablet, chewable, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, chewable - Oral, Tablet, multilayer - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Solution / drops, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets

Productive cough

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Syrup - Oral, Syrup, Suspension - Oral, Suspension, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet - Oral, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Tablet, coated, Tablet, extended release, Tablet, extended release - Oral, Granule, Capsule - Oral, Granule - Oral, Suspension, extended release - Oral, Kit, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Suspension, extended release, Tablet, sugar coated - Oral, Tablet, multilayer, Lozenge - Oral, Tablet, chewable, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, chewable - Oral, Tablet, multilayer - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Solution / drops, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets

Rhinorrhea

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Syrup - Oral, Syrup, Suspension - Oral, Suspension, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet - Oral, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Tablet, coated, Tablet, extended release, Tablet, extended release - Oral, Granule, Capsule - Oral, Granule - Oral, Suspension, extended release - Oral, Kit, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Suspension, extended release, Tablet, sugar coated - Oral, Tablet, multilayer, Lozenge - Oral, Tablet, chewable, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, chewable - Oral, Tablet, multilayer - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Solution / drops, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets

House Dust Mite Allergy

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Syrup - Oral, Syrup, Suspension - Oral, Suspension, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet - Oral, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Tablet, coated, Tablet, extended release, Tablet, extended release - Oral, Granule, Capsule - Oral, Granule - Oral, Suspension, extended release - Oral, Kit, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Suspension, extended release, Tablet, sugar coated - Oral, Tablet, multilayer, Lozenge - Oral, Tablet, chewable, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, chewable - Oral, Tablet, multilayer - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Solution / drops, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets

Inflammation

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Syrup - Oral, Syrup, Suspension - Oral, Suspension, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet - Oral, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Tablet, coated, Tablet, extended release, Tablet, extended release - Oral, Granule, Capsule - Oral, Granule - Oral, Suspension, extended release - Oral, Kit, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Suspension, extended release, Tablet, sugar coated - Oral, Tablet, multilayer, Lozenge - Oral, Tablet, chewable, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, chewable - Oral, Tablet, multilayer - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Solution / drops, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets

IgA Vasculitis

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Syrup - Oral, Syrup, Suspension - Oral, Suspension, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet - Oral, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Tablet, coated, Tablet, extended release, Tablet, extended release - Oral, Granule, Capsule - Oral, Granule - Oral, Suspension, extended release - Oral, Kit, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Suspension, extended release, Tablet, sugar coated - Oral, Tablet, multilayer, Lozenge - Oral, Tablet, chewable, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, chewable - Oral, Tablet, multilayer - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Solution / drops, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets

Nose

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Syrup - Oral, Syrup, Suspension - Oral, Suspension, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet - Oral, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Tablet, coated, Tablet, extended release, Tablet, extended release - Oral, Granule, Capsule - Oral, Granule - Oral, Suspension, extended release - Oral, Kit, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Suspension, extended release, Tablet, sugar coated - Oral, Tablet, multilayer, Lozenge - Oral, Tablet, chewable, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, chewable - Oral, Tablet, multilayer - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Solution / drops, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets

Acute Bronchitis

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Syrup - Oral, Syrup, Suspension - Oral, Suspension, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet - Oral, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Tablet, coated, Tablet, extended release, Tablet, extended release - Oral, Granule, Capsule - Oral, Granule - Oral, Suspension, extended release - Oral, Kit, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Suspension, extended release, Tablet, sugar coated - Oral, Tablet, multilayer, Lozenge - Oral, Tablet, chewable, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, chewable - Oral, Tablet, multilayer - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Solution / drops, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets

Asthma

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Syrup - Oral, Syrup, Suspension - Oral, Suspension, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet - Oral, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Tablet, coated, Tablet, extended release, Tablet, extended release - Oral, Granule, Capsule - Oral, Granule - Oral, Suspension, extended release - Oral, Kit, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Suspension, extended release, Tablet, sugar coated - Oral, Tablet, multilayer, Lozenge - Oral, Tablet, chewable, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, chewable - Oral, Tablet, multilayer - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Solution / drops, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets

upper respiratory symptoms

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Syrup - Oral, Syrup, Suspension - Oral, Suspension, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet - Oral, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Tablet, coated, Tablet, extended release, Tablet, extended release - Oral, Granule, Capsule - Oral, Granule - Oral, Suspension, extended release - Oral, Kit, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Suspension, extended release, Tablet, sugar coated - Oral, Tablet, multilayer, Lozenge - Oral, Tablet, chewable, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, chewable - Oral, Tablet, multilayer - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Solution / drops, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets

Conjunctivitis

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Syrup - Oral, Syrup, Suspension - Oral, Suspension, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet - Oral, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Tablet, coated, Tablet, extended release, Tablet, extended release - Oral, Granule, Capsule - Oral, Granule - Oral, Suspension, extended release - Oral, Kit, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Suspension, extended release, Tablet, sugar coated - Oral, Tablet, multilayer, Lozenge - Oral, Tablet, chewable, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, chewable - Oral, Tablet, multilayer - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Solution / drops, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets

Upper respiratory tract congestion

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Syrup - Oral, Syrup, Suspension - Oral, Suspension, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet - Oral, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Tablet, coated, Tablet, extended release, Tablet, extended release - Oral, Granule, Capsule - Oral, Granule - Oral, Suspension, extended release - Oral, Kit, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Suspension, extended release, Tablet, sugar coated - Oral, Tablet, multilayer, Lozenge - Oral, Tablet, chewable, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, chewable - Oral, Tablet, multilayer - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Solution / drops, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets

Cold

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Syrup - Oral, Syrup, Suspension - Oral, Suspension, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet - Oral, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Tablet, coated, Tablet, extended release, Tablet, extended release - Oral, Granule, Capsule - Oral, Granule - Oral, Suspension, extended release - Oral, Kit, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Suspension, extended release, Tablet, sugar coated - Oral, Tablet, multilayer, Lozenge - Oral, Tablet, chewable, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, chewable - Oral, Tablet, multilayer - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Solution / drops, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets

Asthma

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Syrup - Oral, Syrup, Suspension - Oral, Suspension, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet - Oral, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Tablet, coated, Tablet, extended release, Tablet, extended release - Oral, Granule, Capsule - Oral, Granule - Oral, Suspension, extended release - Oral, Kit, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Suspension, extended release, Tablet, sugar coated - Oral, Tablet, multilayer, Lozenge - Oral, Tablet, chewable, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, chewable - Oral, Tablet, multilayer - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Solution / drops, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets

Dermatitis, Allergic Contact

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Syrup - Oral, Syrup, Suspension - Oral, Suspension, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet - Oral, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Tablet, coated, Tablet, extended release, Tablet, extended release - Oral, Granule, Capsule - Oral, Granule - Oral, Suspension, extended release - Oral, Kit, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Suspension, extended release, Tablet, sugar coated - Oral, Tablet, multilayer, Lozenge - Oral, Tablet, chewable, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Tablet, chewable - Oral, Tablet, multilayer - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit; Tablet; Tablet, extended release, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Kit; Tablet; Tablet, extended release - Oral, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Solution / drops, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets

Warnings

There are 20 known major drug interactions with Tussionex Pennkinetic.

Common Tussionex Pennkinetic Drug Interactions

Drug Name

Risk Level

Description

Amoxapine

Major

The metabolism of Amoxapine can be decreased when combined with Chlorpheniramine.

Anagrelide

Major

The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Anagrelide.

Arsenic trioxide

Major

The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Arsenic trioxide.

Artemether

Major

The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Artemether.

Asenapine

Major

The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Asenapine.

Tussionex Pennkinetic Toxicity & Overdose Risk

The toxic dose of the drug for rats is 306mg/kg, 130mg/kg for mice, and 198mg/kg for guinea pigs. It can also be mildly toxic to women who are of childbearing age.

image of a doctor in a lab doing drug, clinical research

Tussionex Pennkinetic Novel Uses: Which Conditions Have a Clinical Trial Featuring Tussionex Pennkinetic?

163 active clinical trials are assessing the potential of Tussionex Pennkinetic in providing relief for Allergy to Vaccines, Ocular Symptoms and Coughing.

Condition

Clinical Trials

Trial Phases

Migraine

47 Actively Recruiting

Phase 4, Not Applicable, Phase 1, Phase 3, Phase 2, Early Phase 1

Asthma

85 Actively Recruiting

Phase 1, Phase 4, Early Phase 1, Not Applicable, Phase 2, Phase 3

Transfusion Reaction

0 Actively Recruiting

Pink Eye

0 Actively Recruiting

Nasal Congestion

0 Actively Recruiting

Hypersensitivity

1 Actively Recruiting

Phase 4

Headache

0 Actively Recruiting

ocular hyperemia

0 Actively Recruiting

Influenza

0 Actively Recruiting

Conjunctivitis

0 Actively Recruiting

Coughing

0 Actively Recruiting

Airway secretion clearance therapy

0 Actively Recruiting

Nose

0 Actively Recruiting

Allergy to vaccine

0 Actively Recruiting

Angioedema

0 Actively Recruiting

Rhinorrhea

0 Actively Recruiting

Seasonal Allergic Conjunctivitis

0 Actively Recruiting

Cold

0 Actively Recruiting

Lacrimal Apparatus Diseases

0 Actively Recruiting

Coughing

0 Actively Recruiting

Tussionex Pennkinetic Reviews: What are patients saying about Tussionex Pennkinetic?

5

Patient Review

8/27/2008

Tussionex Pennkinetic for Cough

I found real relief from my cough with this syrup. It was a bit pricey, but worth every penny in my opinion. A few doses really helped me out and I'm feeling much better now.

5

Patient Review

6/24/2008

Tussionex Pennkinetic for Cough

I was really struggling with a bronchial cough and it was starting to interfere with my daily life. My friends were concerned and took me to the ER, where I was diagnosed and given this medication. It's been a huge help.

5

Patient Review

11/12/2008

Tussionex Pennkinetic for Cough

This medication helped me a lot by breaking up my deep chest cough. I was afraid that I would get pneumonia, but this treatment really worked well for me. The only downside is that it makes me feel very drugged, but I don't mind because it's helping me to recover.

5

Patient Review

11/7/2008

Tussionex Pennkinetic for Cough

This medication makes me drowsy, but it's really effective.

5

Patient Review

12/3/2008

Tussionex Pennkinetic for Cough

This is by far the best cough medicine I've ever taken. I have asthma and recurring bronchitis, and this was prescribed to me for pneumonia 10 years ago. It completely stopped the chest pain and coughing. A little goes a long way with this one - be careful not to take too much!

5

Patient Review

12/11/2008

Tussionex Pennkinetic for Cough

This cough medicine is fantastic. It not only got rid of my cough, but it also left me feeling incredibly happy and euphoric.

5

Patient Review

1/5/2009

Tussionex Pennkinetic for Cough

This medication is the only thing that helps control my chronic asthma.

5

Patient Review

11/29/2008

Tussionex Pennkinetic for Cough

This medication was a huge help for my chronic cough.

5

Patient Review

10/16/2008

Tussionex Pennkinetic for Cough

This drug has been great for me. As a firefighter and EMT, I've been exposed to a lot of different things that have led to pleurisy and other respiratory issues. It's also helped with my allergies which can be really bad.

5

Patient Review

2/11/2009

Tussionex Pennkinetic for Cold Symptoms

This treatment is great for controlling coughs.

4.7

Patient Review

10/20/2008

Tussionex Pennkinetic for Cold Symptoms

I had an upper respiratory infection that made it difficult to sleep due to coughing. I took this medication and it completely knocked me out. I slept through the night without any issues and woke up feeling refreshed.

4.7

Patient Review

5/2/2008

Tussionex Pennkinetic for Cough

4.3

Patient Review

2/14/2009

Tussionex Pennkinetic for Cough

I had a severe cough for three days and this medication helped me immensely. I was also taking prednisone and levaquin, but I credit this drug for helping me get over the hump.

4.3

Patient Review

2/18/2009

Tussionex Pennkinetic for Cough

I find that this helps me with my cough, but I get hiccups afterwards which can last for hours.

3.7

Patient Review

1/25/2009

Tussionex Pennkinetic for Cough

I was given this cough syrup as part of a series of psychotropic drugs, but it made me extremely drowsy, caused hallucinations, and threw off my balance. I don't think this was the right medication for me.

3.7

Patient Review

1/16/2009

Tussionex Pennkinetic for Cough

If I'm still coughing, does that mean I need to renew this medication for my asthma? It's been really bad lately.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about tussionex pennkinetic

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is tussionex a hydrocodone?

"This product is a long-acting hydrocodone-containing cough medication."

Answered by AI

What is in the cough medicine Tussionex?

"This medication contains two active ingredients, hydrocodone and chlorpheniramine. Hydrocodone is a narcotic cough suppressant while chlorpheniramine is an antihistamine."

Answered by AI

How much hydrocodone is Tussionex Pennkinetic?

"You should shake Tussionex Pennkinetic Extended-Release Suspension well before using it. You should also rinse the measuring device with water after each use."

Answered by AI

What is the drug tussionex used for?

"Chlorpheniramine is an antihistamine that reduces allergy symptoms such as watery eyes, runny nose, and sneezing.

This product is used to treat coughs and other symptoms caused by the common cold or allergies. It contains hydrocodone, an opioid cough suppressant that reduces the urge to cough, and chlorpheniramine, an antihistamine that reduces allergy symptoms such as watery eyes, runny nose, and sneezing."

Answered by AI

Clinical Trials for Tussionex Pennkinetic

Image of Johns Hopkins Bayview Medical Center in Baltimore, United States.

VR-Enhanced PMR for Post-Burn Symptoms

18+
All Sexes
Baltimore, MD

The goal of this clinical trial is to learn whether progressive muscle relaxation (PMR), delivered either alone or enhanced with virtual reality (VR), can help treat chronic symptom, such as pain, itch, anxiety, sleep disturbances, and fatigue, in adult burn survivors. The main questions it aims to answer are: * Does VR-enhanced PMR (VR-PMR) reduce chronic pain, anxiety, itch, sleep disturbances, and fatigue more effectively than standard PMR? * Is VR-PMR a feasible and acceptable self-administered home-based intervention for burn survivors? Researchers will compare two self-administered intervention conditions, VR-enhanced PMR and standard PMR, using a randomized to sequence crossover design to see if VR technology enhances the therapeutic effects of PMR on chronic symptom management in burn survivors. Participants will: * Complete home-based sessions of VR-enhanced PMR * Complete home-based sessions of standard PMR * Report symptoms such as pain, itch, anxiety, sleep disturbances, and fatigue throughout the study * Use VR equipment provided for the intervention period (during the VR-PMR arm)

Recruiting
Has No Placebo

Johns Hopkins Bayview Medical Center

Sheera Lerman Zohar, PhD

Have you considered Tussionex Pennkinetic clinical trials?

We made a collection of clinical trials featuring Tussionex Pennkinetic, we think they might fit your search criteria.
Go to Trials
Image of Arizona State University in Phoenix, United States.

App-based Breathing Program for Migraine

18+
All Sexes
Phoenix, AZ

Migraine is one of the most common neurological disorders, characterized by recurrent headaches, sensitivity to light and movement, nausea, and autonomic dysregulation. Although mind-body interventions like biofeedback have shown their efficacy, they remain underutilized due to barriers such as transportation, time constraints, lack of awareness, stigma, and cost. A targeted approach to enhancing HRV is HRV biofeedback (HRVB), a technique using visual or auditory feedback to help people regulate HRV through slow-paced breathing and positive emotional regulation to promote ANS balance and emotional resilience. Investigators will conduct a remotely delivered pilot RCT of an 8-week, 10 min/day, novel app-based HRVB intervention compared to a sham control intervention (matching intervention time and attention with no biofeedback component) in adult with chronic migraine. Investigators hypothesize data collected from the study will: a) support the feasibility and acceptability of the remotely delivered app-based HRVB intervention among adults with chronic migraine, and b) provide insights into refining the intervention by examining patterns of change in migraine and psychological outcomes from pre- to post-intervention.

Waitlist Available
Online Trial

Arizona State University

Have you considered Tussionex Pennkinetic clinical trials?

We made a collection of clinical trials featuring Tussionex Pennkinetic, we think they might fit your search criteria.
Go to Trials
Image of Johns Hopkins Medicine in Baltimore, United States.

Embolization for Migraine

18 - 80
All Sexes
Baltimore, MD

This study is to test the safety and feasibility of a procedure called embolization of the middle meningeal arteries (MMA), using a product called Onyx. Embolization creates a plug in the arteries. MMA embolization with Onyx is not approved for use in patients with migraines, but is currently used in patients with subdural hematomas. The FDA is allowing the use of Onyx in this study. It is thought that by using Onyx to block the middle meningeal arteries, the amount of migraine-causing substances which are released into the brain's bloodstream will be reduced. The company that manufactures Onyx, Medtronic, is providing the supplies for this study. Participants will be in the study for about 8 months after enrolling, including 6 months of follow up after the procedure. The participants will be asked to complete a daily headache diary and continue the participant's regular migraine medications. Participants will also have several clinic visits and be asked to provide blood samples for research.

Waitlist Available
Has No Placebo

Johns Hopkins Medicine

Risheng Xu, MD, PhD

Medtronic

Image of National Institutes of Health Clinical Center in Bethesda, United States.

BPL-1357 for Flu

18 - 55
All Sexes
Bethesda, MD

Background: Influenza (flu) infections are a serious global health threat. Each year, between 3 and 5 million people get the flu, and up to 500,000 die from it. Current vaccines protect against seasonal flus, but broader vaccines are needed to protect against potential flu pandemics. Objective: To test an experimental flu vaccine. Eligibility: Healthy people aged 18 to 55 years. Design: The study will last 5 to 8 months and has 2 phases, A and B. The study vaccine will be given either as a shot in the arm or as a nasal spray. Participants will receive 1 of 3 combinations: (1) study vaccine in the nose and placebo in the arm; (2) placebo in the nose and study vaccine in the arm; or (3) placebo in the nose and placebo in the arm. A placebo is just like the real vaccine but contains no active ingredients. Phase A: Participants will have 5 clinic visits over 56 days. They will receive a shot and a nasal spray at 2 of the visits, 28 days apart. At each visit, they will have a physical exam, with tests of their blood, urine, and nasal secretions. They will check their temperature at home and record any symptoms for 7 days after each vaccine. Phase B: Participants will stay in the hospital for at least 9 days. They will be infected with a flu virus. They will provide blood, urine, and nasal fluid samples. They will have tests of their heart function. They will remain in the hospital until they test negative for the flu 2 days in a row. They will have 2 follow-up visits, 4 and 8 weeks after leaving the hospital.

Phase 2
Waitlist Available

National Institutes of Health Clinical Center (+1 Sites)

Luca T Giurgea, M.D.

Have you considered Tussionex Pennkinetic clinical trials?

We made a collection of clinical trials featuring Tussionex Pennkinetic, we think they might fit your search criteria.
Go to Trials